Abstract:Objective: To investigate whether the presence of hepatitis B virus (HBV) in oocytes and embryos affects pregnancy outcomes for in vitro fertilization and embryo transfer (ET) as well as is related to the vertical transmission of HBV to children. Design: Retrospective cohort study. Setting: A university-affiliated fertility center. Patients: This study included 167 couples with at least 1 hepatitis B surface antigen-seropositive partner. These couples underwent in vitro fertilization-ET, and the discarded oocytes and embryos had been tested for HBV. Couples with HBV-positive oocytes or embryos were categorized as the positive group, whereas those couples with HBV-negative oocytes and embryos served as the negative group. Interventions: None. Main outcome measures: Pregnancy outcomes and the rate of children's HBV infection. Results: The pregnancy outcomes of fresh and frozen ETs were not associated with the presence of HBV in the oocytes and embryos. Of the 106 infants born, 1 child whose mother tested positive for hepatitis B surface antigen but had negative oocytes and embryos was infected with HBV. Additionally, 26.09% of children who had been administered passive immunization and active vaccinations did not reach protective levels of anti-HBV antibodies (hepatitis B surface antibodies) and became nonresponders. The negative rate of children's hepatitis B surface antibody was associated with the presence of HBV in oocytes and embryos (odds ratio, 3.01; 95% confidence interval, 1.04-9.25). Conclusions: The presence of HBV in oocytes and embryos did not affect pregnancy outcomes or result in the vertical transmission of HBV to the offspring of HBV carriers. Follow-up is needed for HBV-vaccinated children with an HBV-infected parent. Booster vaccinations are necessary for continued protection.

Presence of HBsAg, HBcAg, and HBVDNA in ovary and ovum of the patients with chronic hepatitis B virus infection.

The presence and expression of the hepatitis B virus in human oocytes and embryos

Expression of HBsAg and HBcAg in the Ovaries and Ova of Patients with Chronic Hepatitis B

Hepatitis B Virus Expression and Replication in Ovum and the Influencing Factors.

Hepatitis B Virus in Oocytes and Embryos: Pregnancy Outcomes and Children’s Health

Expression of HCVAg in ovary and oviduct of the patients with chronic hepatitis C

[Relationship Between the Expression of HBV DNA, HBV Cccdna in Human Ovary Tissues and the HBV Intrauterine Infection].

Detection of HBsAg, HBcAg, and HBV DNA in Ovarian Tissues from Patients with HBV Infection

Expression and Location & Clinical Signifieance in Ovarian Tissues from Patients with HBV Infection

Correlation Between Vertical Transmission of Hepatitis B Virus and the Expression of HBsAg in Ovarian Follicles and Placenta

Relationship Between HBV Cccdna Expression in the Human Ovary and Vertical Transmission of HBV.

Expression of HBV infectious related protein human Annexin V in ovary tissue

Analysis of the Factors Correlated to HBV Cccdna in Human Ovarian in Pregnant Women with Hepatitis B E Antigen Positive

Study of HBV-DNA in Ovarian Granulosa Cells of Hepatitis B Carriers

The Presence of HBV Mrna in the Fertilized in Vitro Embryo of HBV Patients Confirms Vertical Transmission of HBV Via the Ovum

Relation between HBV mRNA in the embryo of HBV patients and vertical transmission

Hepatitis B virus infection primary cultured human granulosa cells in vitro

Ovarian HBV replication following ovulation induction in female hepatitis B carriers undergoing IVF treatment: A prospective observational study

Hepatitis B virus in oocytes and embryos: pregnancy outcomes and children's health

Mutations in hepatitis B virus DNA from patients with coexisting HBsAg and anti-HBs.

Analyzing the Detrimental Effects of Female Chronic Hepatitis B Virus DNA on Ovarian Reserve Function and Results of in Vitro Fertilization